HOB Biotech Group Corp.,Ltd
Shanghai Stock ExchangeTotal Valuation
HOB Biotech Group Corp.,Ltd carries a market capitalization of 6.62B, placing it among publicly traded companies globally. Its enterprise value stands at 7.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.62B |
| Enterprise Value | 7.46B |
Share Statistics
HOB Biotech Group Corp.,Ltd currently has 63.06M shares outstanding.
| Shares Outstanding | 63.06M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
HOB Biotech Group Corp.,Ltd trades at a trailing price-to-earnings ratio of 255.93. The price-to-sales ratio is 19.06, and the price-to-book ratio stands at 32.12.
| PE Ratio | 255.93 |
| PS Ratio | 19.06 |
| PB Ratio | 32.12 |
| P/TBV Ratio | 9.24 |
| P/FCF Ratio | 71.90 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, HOB Biotech Group Corp.,Ltd trades at an EV/EBITDA multiple of 224.34 and an EV/FCF ratio of 70.32. The EV/Sales ratio of 19.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 224.34 provides insight into valuation relative to core operating earnings.
| EV / Sales | 19.16 |
| EV / EBITDA | 224.34 |
| EV / EBIT | 224.34 |
| EV / FCF | 70.32 |
Financial Position
HOB Biotech Group Corp.,Ltd maintains a current ratio of 1.67, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.92, indicating elevated leverage, while an interest coverage ratio of 11.13 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.67 |
| Quick Ratio | 0.46 |
| Debt / Equity | 12.92 |
| Debt / EBITDA | 3.17 |
| Interest Coverage | 11.13 |
Financial Efficiency
HOB Biotech Group Corp.,Ltd posts a return on equity of 12.85 and a return on invested capital of 3.48.
| Return on Equity (ROE) | 12.85 |
| Return on Assets (ROA) | 2.95 |
| Return on Invested Capital (ROIC) | 3.48 |
| Return on Capital Employed (ROCE) | 9.64 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.36 |
Taxes
Over the trailing twelve months, HOB Biotech Group Corp.,Ltd has paid 1.31M in income taxes, reflecting an effective tax rate of 4.31.
| Income Tax | 1.31M |
| Effective Tax Rate | 4.31 |
Stock Price Statistics
HOB Biotech Group Corp.,Ltd's stock has declined approximately -16.91927% over the past 52 weeks. The 50-day moving average sits at 116.60, while the 200-day moving average is 147.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.91927% |
| 50-Day Moving Average | 116.60 |
| 200-Day Moving Average | 147.36 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, HOB Biotech Group Corp.,Ltd generated 389.19M in revenue and converted that into 28.99M in net income, yielding earnings per share of 0.53. EBITDA reached 33.24M, while operating income came in at 33.24M.
| Revenue | 389.19M |
| Gross Profit | 240.49M |
| Operating Income | 33.24M |
| Pretax Income | 30.30M |
| Net Income | 28.99M |
| EBITDA | 33.24M |
| EBIT | 33.24M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
HOB Biotech Group Corp.,Ltd holds 67.23M in cash and equivalents against 105.23M in total debt, resulting in a net debt position of 33.79M. Total book value stands at 231.00M, with working capital of 97.02M providing operational flexibility.
| Cash & Cash Equivalents | 67.23M |
| Total Debt | 105.23M |
| Net Debt | 33.79M |
| Equity (Book Value) | 231.00M |
| Book Value Per Share | 4.23 |
| Working Capital | 97.02M |
Cash Flow
After subtracting -103.20M in capital expenditures, free cash flow totaled -103.20M - equivalent to -1.89 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -103.20M |
| Free Cash Flow | -103.20M |
| FCF Per Share | -1.89 |
Margins
HOB Biotech Group Corp.,Ltd operates with a gross margin of 61.79, reflecting its pricing power and cost economics. The operating margin of 8.54 and net profit margin of 7.45 provide insight into operational efficiency.
| Gross Margin | 61.79 |
| Operating Margin | 8.54 |
| Pretax Margin | 7.79 |
| Profit Margin | 7.45 |
| EBITDA Margin | 8.54 |
Dividends & Yields
The company's payout ratio of 76.85 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.41 |
| Dividend Yield | N/A |
| Payout Ratio | 76.85 |
| Shareholder Yield | 0.10 |
| FCF Yield | 1.39 |
Scores
HOB Biotech Group Corp.,Ltd posts an Altman Z-Score of 27.86, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 27.86 |